Indian Peptides and Heparin Market worth USD 883.0 Million by 2022, at a CAGR of 15.0%
PUNE, India, 2020-Jul-08 — /EPR Network/ — Increasing prevalence of chronic diseases such as diabetes, cancer, and osteoporosis and favorable government policies for the pharmaceutical [read full press release…]